Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v2.4.0.8
Condensed Consolidated Statements of Operations (USD $)
3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Costs and expenses:        
Research and development $ 1,118,251 $ 240,114 $ 2,192,031 $ 289,700
General and administrative 1,302,236 103,257 2,357,483 165,804
Total costs and expenses 2,420,487 343,371 4,549,514 455,504
Loss from operations (2,420,487) (343,371) (4,549,514) (455,504)
Other expense, (income) 5,385 (57) 15,381 (57)
Net loss $ (2,425,872) $ (343,314) $ (4,564,895) $ (455,447)
Net loss per share - basic and diluted (in dollars per share) $ (0.08) $ (0.03) $ (0.14) $ (0.05)
Weighted average common shares outstanding:        
Basic and diluted (in shares) 32,000,000 10,000,000 32,000,000 10,000,000